These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10418172)

  • 41. p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients.
    Murakami I; Hiyama K; Ishioka S; Yamakido M; Kasagi F; Yokosaki Y
    Clin Cancer Res; 2000 Feb; 6(2):526-30. PubMed ID: 10690534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smoking habit and genetic factors associated with lung cancer in a population highly exposed to arsenic.
    Adonis M; Martínez V; Marín P; Berrios D; Gil L
    Toxicol Lett; 2005 Oct; 159(1):32-7. PubMed ID: 16099114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.
    Horio Y; Takahashi T; Kuroishi T; Hibi K; Suyama M; Niimi T; Shimokata K; Yamakawa K; Nakamura Y; Ueda R
    Cancer Res; 1993 Jan; 53(1):1-4. PubMed ID: 8380124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genes and enzymes of the xenobiotic-metabolizing system in cancer pathology].
    Liakhovich VV; Vavilin VA; Gutkina NI; Laktionova IP; Makarova SI; Mitrofanov DV; Ostashevskiĭ VA; Chasovnikova OB
    Vopr Med Khim; 1997; 43(5):330-8. PubMed ID: 9446323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility.
    Cascorbi I; Brockmöller J; Roots I
    Cancer Res; 1996 Nov; 56(21):4965-9. PubMed ID: 8895751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [P53 and P16 gene mutations in non-small cell lung cancer].
    Jassem E; Ramlau R; Dziadziuszko R; Szymanowska A; Jakóbkiewicz J; Lamperska K; Kobierska G; Skokowski J; Dyszkiewicz W; Mackiewicz A; Zylicz M; Jassem J
    Pneumonol Alergol Pol; 2002; 70(1-2):64-70. PubMed ID: 12148179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
    Przygodzki RM; Bennett WP; Guinee DG; Khan MA; Freedman A; Shields PG; Travis WD; Jett JR; Tazelaar H; Pairolero P; Trastek V; Liotta LA; Harris CC; Caporaso NE
    Pharmacogenetics; 1998 Dec; 8(6):503-11. PubMed ID: 9918134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use.
    Lazarus P; Sheikh SN; Ren Q; Schantz SP; Stern JC; Richie JP; Park JY
    Carcinogenesis; 1998 Mar; 19(3):509-14. PubMed ID: 9525287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland.
    Rusin M; Butkiewicz D; Malusecka E; Zborek A; Harasim J; Czyzewski K; Bennett WP; Shields PG; Weston A; Welsh JA; Krzyzowska-Gruca S; Chorazy M; Harris CC
    Br J Cancer; 1999 Jul; 80(9):1445-52. PubMed ID: 10424749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
    Li W; Yue W; Yang X; Zhang C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYP1A1 gene polymorphisms as a risk factor for pterygium.
    Young CH; Lo YL; Tsai YY; Shih TS; Lee H; Cheng YW
    Mol Vis; 2010 Jun; 16():1054-8. PubMed ID: 20596254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci.
    Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
    Br J Cancer; 1997; 75(9):1385-8. PubMed ID: 9155064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between GSTM1 and CYP1A1 polymorphisms and survival in oral cancer patients.
    Shukla D; Dinesh Kale A; Hallikerimath S; Yerramalla V; Subbiah V; Mishra S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):304-10. PubMed ID: 23681307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Individual susceptibility factors in the risk of lung cancer].
    Stücker I
    Ann Pathol; 1997; 17 Suppl 5():23-4. PubMed ID: 9453718
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic polymorphisms in patients with endometriosis: an analytical study in Goiânia (Central West of Brazil).
    Silva KS; Moura KK
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.
    Bennett WP; Hussain SP; Vahakangas KH; Khan MA; Shields PG; Harris CC
    J Pathol; 1999 Jan; 187(1):8-18. PubMed ID: 10341702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic polymorphisms of CYP1A1, GSTM1 and P53 genes in a unique Siberian population of Tundra Nentsi and its pharmacogenetic importance.
    Duzhak TG; Osipova LP; Posukh OL; Chasovnikova OB; Ostashevskii VI; Lyakhovich VV
    Int J Circumpolar Health; 2001 Apr; 60(2):228-34. PubMed ID: 11507974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactive potential of genetic polymorphism in Xenobiotic metabolising and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians.
    Bhardwaj A; Bahl C; Sharma S; Singh N; Behera D
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():15-24. PubMed ID: 29412865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases.
    Fontana X; Peyrottes I; Rossi C; Leblanc-Talent P; Ettore F; Namer M; Bussière F
    Mutat Res; 1998 Jul; 403(1-2):45-53. PubMed ID: 9726005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.